Roche Nominates Former Takeda CEO Christophe Weber to Board

F. Hoffmann-La Roche Ltd··CHUSJP·Read original
1▲1 ▼0Impact / 5
Summary · why it matters

Roche announced that the Board of Directors of Roche Holding Ltd has approved proposing Dr. Christophe Weber, former CEO of Takeda Pharmaceuticals, for election to the Board of Directors at Roche's Annual General Meeting on March 9, 2027. Roche Chairman Severin Schwan said he is pleased the company was able to propose Christophe Weber for election, adding that Weber's intimate knowledge of the healthcare industry and his broad leadership experience will further strengthen the Board. Roche, founded in Basel, Switzerland in 1896, is a healthcare company spanning diagnostics, medicines and digital solutions, and is a leading provider of transformative medicines and diagnostics for millions of people in over 150 countries. Genentech in the United States is a fully owned subsidiary in the Roche Group, and Roche is the majority shareholder in Chugai Pharmaceutical.

Impact on assets 4

Biotech & Genomic Medicine▲ · 2 stocks
Health Care▲ · 1 stocks
Roche Holding AG
ROP
▲ PositiveCapitalrelevance

Roche proposes former Takeda CEO Christophe Weber for election to its Board of Directors

Semiconductors▲ · 1 stocks

Off-coverage companies 1

Genentech, Inc.Private± Mixed
relevance

© 2026 MarketIVNews